Header Logo

SAMUEL MOK

TitleProfessor
InstitutionMD Anderson
DepartmentGynecological Oncology & Reproductive Medicine
Address1515 Holcombe Blvd
Houston TX 77030-4009
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ferri-Borgogno S, Burks JK, Seeley EH, McKee TD, Stolley DL, Basi AV, Gomez JA, Gamal BT, Ayyadhury S, Lawson BC, Yates MS, Birrer MJ, Lu KH, Mok SC. Molecular, Metabolic, and Subcellular Mapping of the Tumor Immune Microenvironment via 3D Targeted and Non-Targeted Multiplex Multi-Omics Analyses. Cancers (Basel). 2024 Feb 20; 16(5). PMID: 38473208; PMCID: PMC10930466.
      Citations: 1     
    2. Chowdhury S, Kennedy JJ, Ivey RG, Murillo OD, Hosseini N, Song X, Petralia F, Calinawan A, Savage SR, Berry AB, Reva B, Ozbek U, Krek A, Ma W, da Veiga Leprevost F, Ji J, Yoo S, Lin C, Voytovich UJ, Huang Y, Lee SH, Bergan L, Lorentzen TD, Mesri M, Rodriguez H, Hoofnagle AN, Herbert ZT, Nesvizhskii AI, Zhang B, Whiteaker JR, Fenyo D, McKerrow W, Wang J, Sch?rer SC, Stathias V, Chen XS, Barcellos-Hoff MH, Starr TK, Winterhoff BJ, Nelson AC, Mok SC, Kaufmann SH, Drescher C, Cieslik M, Wang P, Birrer MJ, Paulovich AG. Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. Cell. 2024 Feb 15; 187(4):1016. PMID: 38364782; PMCID: PMC10935576.
      Citations: 1     Fields:    
    3. Chowdhury S, Kennedy JJ, Ivey RG, Murillo OD, Hosseini N, Song X, Petralia F, Calinawan A, Savage SR, Berry AB, Reva B, Ozbek U, Krek A, Ma W, da Veiga Leprevost F, Ji J, Yoo S, Lin C, Voytovich UJ, Huang Y, Lee SH, Bergan L, Lorentzen TD, Mesri M, Rodriguez H, Hoofnagle AN, Herbert ZT, Nesvizhskii AI, Zhang B, Whiteaker JR, Fenyo D, McKerrow W, Wang J, Sch?rer SC, Stathias V, Chen XS, Barcellos-Hoff MH, Starr TK, Winterhoff BJ, Nelson AC, Mok SC, Kaufmann SH, Drescher C, Cieslik M, Wang P, Birrer MJ, Paulovich AG. Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. Cell. 2023 08 03; 186(16):3476-3498.e35. PMID: 37541199; PMCID: PMC10414761.
      Citations: 4     Fields:    Translation:Humans
    4. Han C, Leonardo TR, Romana-Souza B, Shi J, Keiser S, Yuan H, Altakriti M, Ranzer MJ, Ferri-Borgogno S, Mok SC, Koh TJ, Hong SJ, Chen L, DiPietro LA. Microfibril-associated protein 5 and the regulation of skin scar formation. Sci Rep. 2023 05 30; 13(1):8728. PMID: 37253753; PMCID: PMC10229580.
      Citations:    Fields:    Translation:AnimalsCells
    5. Ferri-Borgogno S, Zhu Y, Sheng J, Burks JK, Gomez JA, Wong KK, Wong STC, Mok SC. Spatial Transcriptomics Depict Ligand-Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors. Cancer Res. 2023 05 02; 83(9):1503-1516. PMID: 36787106; PMCID: PMC10159916.
      Citations: 2     Fields:    Translation:HumansCells
    6. Khlebus E, Vuttaradhi VK, Welte T, Khurana N, Celestino J, Beird HC, Gumbs C, Little L, Legarreta AF, Fellman BM, Nguyen T, Lawson B, Ferri-Borgogno S, Mok SC, Broaddus RR, Gershenson DM, Futreal PA, Hillman RT. Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors. Mol Cancer Res. 2023 05 01; 21(5):483-494. PMID: 37068116; PMCID: PMC10150241.
      Citations:    Fields:    Translation:Humans
    7. Osann K, Wenzel L, McKinney C, Wagner L, Cella D, Fulci G, Scroggins MJ, Lankes HA, Wang V, Nephew KP, Maxwell GL, Mok SC, Conrads TP, Miller A, Birrer M. Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors. Gynecol Oncol. 2023 04; 171:151-158. PMID: 36905875; PMCID: PMC10681156.
      Citations:    Fields:    Translation:Humans
    8. Eng L, Brual J, Nagee A, Mok S, Fazelzad R, Chaiton M, Saunders DP, Mittmann N, Truscott R, Liu G, Bradbury PA, Evans WK, Papadakos J, Giuliani ME. Reporting of tobacco use and tobacco-related analyses in cancer cooperative group clinical trials: a systematic scoping review. ESMO Open. 2022 12; 7(6):100605. PMID: 36356412; PMCID: PMC9646674.
      Citations:    
    9. Zhang L, Au-Yeung CL, Huang C, Yeung TL, Ferri-Borgogno S, Lawson BC, Kwan SY, Yin Z, Wong ST, Thomas V, Lu KH, Yip KP, Sham JSK, Mok SC. Ryanodine receptor 1-mediated Ca2+ signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes. J Exp Clin Cancer Res. 2022 Aug 11; 41(1):242. PMID: 35953818; PMCID: PMC9373370.
      Citations:    
    10. Wenzel L, Osann K, McKinney C, Cella D, Fulci G, Scroggins MJ, Lankes HA, Wang V, Nephew KP, Maxwell GL, Mok SC, Conrads TP, Miller A, Mannel RS, Gray HJ, Hanjani P, Huh WK, Spirtos N, Leitao MM, Glaser G, Sharma SK, Santin AD, Sperduto P, Lele SB, Burger RA, Monk BJ, Birrer M. Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival. J Natl Cancer Inst. 2021 10 01; 113(10):1369-1378. PMID: 33729494; PMCID: PMC8486331.
      Citations:    Fields:    Translation:Humans
    11. Chung TKH, Doran G, Cheung TH, Yim SF, Yu MY, Worley MJ, Elias KM, Thorner AR, Pedamallu CS, Ojesina AI, Lau KM, Ducar MD, Wong RRY, Wang VW, Nag A, Wollison BM, Dalgarno A, Lee JHS, Yeung SY, Wong L, Horowitz NS, Davis MR, Leung SA, Mu Y, Mok SC, Chan PKS, Lawrence MS, Crum CP, Chiu RWK, Berkowitz RS, Wong YF. Dissection of PIK3CA Aberration for Cervical Adenocarcinoma Outcomes. Cancers (Basel). 2021 Jun 28; 13(13). PMID: 34203201; PMCID: PMC8269188.
      Citations:    
    12. Nagaraja AS, Dood RL, Armaiz-Pena G, Kang Y, Wu SY, Allen JK, Jennings NB, Mangala LS, Pradeep S, Lyons Y, Haemmerle M, Gharpure KM, Sadaoui NC, Rodriguez-Aguayo C, Ivan C, Wang Y, Baggerly K, Ram P, Lopez-Berestein G, Liu J, Mok SC, Cohen L, Lutgendorf SK, Cole SW, Sood AK. Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. JCI Insight. 2021 04 08; 6(7). PMID: 33793425; PMCID: PMC8119210.
      Citations:    Fields:    
    13. Zhu Y, Ferri-Borgogno S, Sheng J, Yeung TL, Burks JK, Cappello P, Jazaeri AA, Kim JH, Han GH, Birrer MJ, Mok SC, Wong STC. SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment. Cancers (Basel). 2021 Apr 08; 13(8). PMID: 33917869; PMCID: PMC8068305.
      Citations: 3     
    14. Hu W, Zhang L, Ferri-Borgogno S, Kwan SY, Lewis KE, Cun HT, Yeung TL, Soliman PT, Tarapore RS, Allen JE, Guan X, Lu KH, Mok SC, Au-Yeung CL. Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436. Cancers (Basel). 2021 Feb 04; 13(4). PMID: 33557446; PMCID: PMC7915108.
      Citations: 2     
    15. Hu W, Zhang L, Ferri-Borgogno S, Kwan SY, Lewis KE, Cun HT, Yeung TL, Soliman PT, Tarapore RS, Allen JE, Guan X, Lu KH, Mok SC, Au-Yeung CL. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers (Basel). 2020 Aug 27; 12(9). PMID: 32867127; PMCID: PMC7563948.
      Citations: 3     
    16. Au-Yeung CL, Yeung TL, Achreja A, Zhao H, Yip KP, Kwan SY, Onstad M, Sheng J, Zhu Y, Baluya DL, Co NN, Rynne-Vidal A, Schmandt R, Anderson ML, Lu KH, Wong STC, Nagrath D, Mok SC. ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment. Nat Commun. 2020 07 15; 11(1):3546. PMID: 32669559; PMCID: PMC7363861.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    17. Shang N, Lee JTY, Huang T, Wang C, Lee TL, Mok SC, Zhao H, Chan WY. Disabled-2: a positive regulator of the early differentiation of myoblasts. Cell Tissue Res. 2020 Sep; 381(3):493-508. PMID: 32607799; PMCID: PMC7431403.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    18. Colvin EK, Howell VM, Mok SC, Samimi G, Vafaee F. Expression of long noncoding RNAs in cancer-associated fibroblasts linked to patient survival in ovarian cancer. Cancer Sci. 2020 May; 111(5):1805-1817. PMID: 32058624; PMCID: PMC7226184.
      Citations: 16     Fields:    Translation:HumansCells
    19. Zhang L, Kwan SY, Wong KK, Solaman PT, Lu KH, Mok SC. Pathogenesis and Clinical Management of Uterine Serous Carcinoma. Cancers (Basel). 2020 Mar 14; 12(3). PMID: 32183290; PMCID: PMC7140057.
      Citations: 6     
    20. Kwan SY, Au-Yeung CL, Yeung TL, Rynne-Vidal A, Wong KK, Risinger JI, Lin HK, Schmandt RE, Yates MS, Mok SC, Lu KH. Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression. Cancers (Basel). 2020 Jan 02; 12(1). PMID: 31906456; PMCID: PMC7016780.
      Citations: 9     
    21. Schwede M, Waldron L, Mok SC, Wei W, Basunia A, Merritt MA, Mitsiades CS, Parmigiani G, Harrington DP, Quackenbush J, Birrer MJ, Culhane AC. The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2020 02; 29(2):509-519. PMID: 31871106; PMCID: PMC7448721.
      Citations: 13     Fields:    Translation:HumansCells
    22. Osmanbeyoglu HU, Shimizu F, Rynne-Vidal A, Alonso-Curbelo D, Chen HA, Wen HY, Yeung TL, Jelinic P, Razavi P, Lowe SW, Mok SC, Chiosis G, Levine DA, Leslie CS. Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers. Nat Commun. 2019 09 25; 10(1):4369. PMID: 31554806; PMCID: PMC6761109.
      Citations: 8     Fields:    Translation:HumansCells
    23. Hinchcliff E, Paquette C, Roszik J, Kelting S, Stoler MH, Mok SC, Yeung TL, Zhang Q, Yates M, Peng W, Hwu P, Jazaeri A. Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature. Cancer Immunol Immunother. 2019 Sep; 68(9):1515-1526. PMID: 31515669; PMCID: PMC11028084.
      Citations: 9     Fields:    Translation:HumansCells
    24. Yeung TL, Leung CS, Yip KP, Sheng J, Vien L, Bover LC, Birrer MJ, Wong STC, Mok SC. Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer. Clin Cancer Res. 2019 11 01; 25(21):6417-6428. PMID: 31332047; PMCID: PMC6825539.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    25. Yeung TL, Sheng J, Leung CS, Li F, Kim J, Ho SY, Matzuk MM, Lu KH, Wong STC, Mok SC. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer. J Natl Cancer Inst. 2019 03 01; 111(3):272-282. PMID: 29860390; PMCID: PMC6410941.
      Citations: 18     Fields:    Translation:HumansCells
    26. Yeung TL, Tsai CC, Leung CS, Au Yeung CL, Thompson MS, Lu KH, Freedman RS, Birrer MJ, Wong KK, Mok SC. ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression. Cancers (Basel). 2018 Nov 22; 10(12). PMID: 30469497; PMCID: PMC6316352.
      Citations: 10     
    27. Nagaraja AS, Dood RL, Armaiz-Pena G, Kang Y, Wu SY, Allen JK, Jennings NB, Mangala LS, Pradeep S, Lyons Y, Haemmerle M, Gharpure KM, Sadaoui NC, Rodriguez-Aguayo C, Ivan C, Wang Y, Baggerly K, Ram P, Lopez-Berestein G, Liu J, Mok SC, Cohen L, Lutgendorf SK, Cole SW, Sood AK. Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. JCI Insight. 2018 Jun 07; 3(11). PMID: 29889660; PMCID: PMC6124403.
      Citations: 3     Fields:    
    28. Lewis KE, Lu KH, Klimczak AM, Mok SC. Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision. Cancers (Basel). 2018 Feb 21; 10(2). PMID: 29466291; PMCID: PMC5836089.
      Citations: 6     
    29. Leung CS, Yeung TL, Yip KP, Wong KK, Ho SY, Mangala LS, Sood AK, Lopez-Berestein G, Sheng J, Wong ST, Birrer MJ, Mok SC. Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance. J Clin Invest. 2018 02 01; 128(2):589-606. PMID: 29251630; PMCID: PMC5785271.
      Citations: 51     Fields:    Translation:HumansAnimalsCells
    30. Vafaee F, Colvin EK, Mok SC, Howell VM, Samimi G. Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis. Sci Rep. 2017 09 04; 7(1):10374. PMID: 28871211; PMCID: PMC5583324.
      Citations: 23     Fields:    Translation:HumansCells
    31. Nagaraja AS, Dood RL, Armaiz-Pena G, Kang Y, Wu SY, Allen JK, Jennings NB, Mangala LS, Pradeep S, Lyons Y, Haemmerle M, Gharpure KM, Sadaoui NC, Rodriguez-Aguayo C, Ivan C, Wang Y, Baggerly K, Ram P, Lopez-Berestein G, Liu J, Mok SC, Cohen L, Lutgendorf SK, Cole SW, Sood AK. Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. JCI Insight. 2017 Aug 17; 2(16). PMID: 28814667; PMCID: PMC5621917.
      Citations: 11     Fields:    
    32. Au-Yeung CL, Yeung TL, Mok SC, Rynne-Vidal A, Jim?nez-Heffernan JA, P?rez-Lozano ML, Cremades-Jimeno L, B?rcena C, Crist?bal-Garc?a I, Fern?ndez-Chac?n C, Sandoval P, L?pez-Cabrera M. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer. J Pathol. 2017 06; 242(2):140-151. PMID: 28247413; PMCID: PMC5468005.
      Citations: 42     Fields:    Translation:HumansAnimalsCells
    33. Yeung TL, Leung CS, Wong KK, Gutierrez-Hartmann A, Kwong J, Gershenson DM, Mok SC. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells. Oncotarget. 2017 Mar 07; 8(10):16951-16963. PMID: 28199976; PMCID: PMC5370013.
      Citations: 36     Fields:    Translation:HumansCells
    34. Pakish JB, Zhang Q, Chen Z, Liang H, Chisholm GB, Yuan Y, Mok SC, Broaddus RR, Lu KH, Yates MS. Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters. Clin Cancer Res. 2017 Aug 01; 23(15):4473-4481. PMID: 28264871; PMCID: PMC5540763.
      Citations: 36     Fields:    Translation:HumansCells
    35. Yang L, Achreja A, Yeung TL, Mangala LS, Jiang D, Han C, Baddour J, Marini JC, Ni J, Nakahara R, Wahlig S, Chiba L, Kim SH, Morse J, Pradeep S, Nagaraja AS, Haemmerle M, Kyunghee N, Derichsweiler M, Plackemeier T, Mercado-Uribe I, Lopez-Berestein G, Moss T, Ram PT, Liu J, Lu X, Mok SC, Sood AK, Nagrath D. Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth. Cell Metab. 2016 11 08; 24(5):685-700. PMID: 27829138; PMCID: PMC7329194.
      Citations: 146     Fields:    Translation:HumansAnimalsCells
    36. Lo CM, Lo JC, Sato PY, Yeung TL, Mok SC, Yip KP. Monitoring of ovarian cancer cell invasion in real time with frequency-dependent impedance measurement. Am J Physiol Cell Physiol. 2016 Dec 01; 311(6):C1040-C1047. PMID: 27784677; PMCID: PMC5504434.
      Citations: 2     Fields:    Translation:HumansCells
    37. Au Yeung CL, Co NN, Tsuruga T, Yeung TL, Kwan SY, Leung CS, Li Y, Lu ES, Kwan K, Wong KK, Schmandt R, Lu KH, Mok SC. Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nat Commun. 2016 Mar 29; 7:11150. PMID: 27021436; PMCID: PMC4820618.
      Citations: 313     Fields:    Translation:HumansCells
    38. Yeung TL, Leung CS, Li F, Wong SS, Mok SC. Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment. Biomolecules. 2016 Jan 06; 6(1):3. PMID: 26751490; PMCID: PMC4808797.
      Citations: 28     Fields:    Translation:HumansCells
    39. Mok SC. Letter from the New Editor-in-Chief. Cancers (Basel). 2016 Jan 06; 8(1). PMID: 26791308; PMCID: PMC4728456.
      Citations:    
    40. Moran-Jones K, Gloss BS, Murali R, Chang DK, Colvin EK, Jones MD, Yuen S, Howell VM, Brown LM, Wong CW, Spong SM, Scarlett CJ, Hacker NF, Ghosh S, Mok SC, Birrer MJ, Samimi G. Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer. Oncotarget. 2015 Dec 29; 6(42):44551-62. PMID: 26575166; PMCID: PMC4792575.
      Citations: 20     Fields:    Translation:HumansCells
    41. Qiu MT, Fan Q, Zhu Z, Kwan SY, Chen L, Chen JH, Ying ZL, Zhou Y, Gu W, Wang LH, Cheng WW, Zeng J, Wan XP, Mok SC, Wong KK, Bao W. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1. Oncotarget. 2015 Oct 13; 6(31):31702-20. PMID: 26397136; PMCID: PMC4741634.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    42. Yeung TL, Leung CS, Yip KP, Au Yeung CL, Wong ST, Mok SC. Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis. Am J Physiol Cell Physiol. 2015 Oct 01; 309(7):C444-56. PMID: 26224579; PMCID: PMC4593771.
      Citations: 138     Fields:    Translation:HumansCells
    43. Guo F, Wang Y, Liu J, Mok SC, Xue F, Zhang W. CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks. Oncogene. 2016 Feb 18; 35(7):816-26. PMID: 25961926.
      Citations: 157     Fields:    Translation:HumansAnimalsCells
    44. Leung CS, Yeung TL, Yip KP, Pradeep S, Balasubramanian L, Liu J, Wong KK, Mangala LS, Armaiz-Pena GN, Lopez-Berestein G, Sood AK, Birrer MJ, Mok SC. Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential. Nat Commun. 2014 Oct 03; 5:5092. PMID: 25277212; PMCID: PMC4185407.
      Citations: 56     Fields:    Translation:HumansCells
    45. Co NN, Iglesias D, Celestino J, Kwan SY, Mok SC, Schmandt R, Lu KH. Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53. Cancer. 2014 Nov 15; 120(22):3457-68. PMID: 25042259; PMCID: PMC4221493.
      Citations: 9     Fields:    Translation:HumansCells
    46. Yeung TL, Leung CS, Mok SC. CAF reprogramming inhibits ovarian cancer progression. Cell Cycle. 2014; 13(24):3783-4. PMID: 25483059; PMCID: PMC4614150.
      Citations: 13     Fields:    Translation:HumansCells
    47. Nowicka A, Marini FC, Solley TN, Elizondo PB, Zhang Y, Sharp HJ, Broaddus R, Kolonin M, Mok SC, Thompson MS, Woodward WA, Lu K, Salimian B, Nagrath D, Klopp AH. Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance. PLoS One. 2013; 8(12):e81859. PMID: 24312594; PMCID: PMC3847080.
      Citations: 42     Fields:    Translation:HumansAnimalsCells
    48. Tsang YT, Deavers MT, Sun CC, Kwan SY, Kuo E, Malpica A, Mok SC, Gershenson DM, Wong KK. KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma. J Pathol. 2013 Dec; 231(4):449-56. PMID: 24549645; PMCID: PMC4095747.
      Citations: 48     Fields:    Translation:HumansCells
    49. Merritt MA, Bentink S, Schwede M, Iwanicki MP, Quackenbush J, Woo T, Agoston ES, Reinhardt F, Crum CP, Berkowitz RS, Mok SC, Witt AE, Jones MA, Wang B, Ince TA. Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes. PLoS One. 2013; 8(11):e80314. PMID: 24303006; PMCID: PMC3841174.
      Citations: 21     Fields:    Translation:HumansAnimalsCells
    50. Wei W, Mok SC, Oliva E, Kim SH, Mohapatra G, Birrer MJ. FGF18 as a prognostic and therapeutic biomarker in ovarian cancer. J Clin Invest. 2013 Oct; 123(10):4435-48. PMID: 24018557; PMCID: PMC3784549.
      Citations: 37     Fields:    Translation:HumansAnimalsCells
    51. Yeung TL, Leung CS, Wong KK, Samimi G, Thompson MS, Liu J, Zaid TM, Ghosh S, Birrer MJ, Mok SC. TGF-? modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. Cancer Res. 2013 Aug 15; 73(16):5016-28. PMID: 23824740; PMCID: PMC3745588.
      Citations: 185     Fields:    Translation:HumansCells
    52. Wong KK, Izaguirre DI, Kwan SY, King ER, Deavers MT, Sood AK, Mok SC, Gershenson DM. Poor survival with wild-type TP53 ovarian cancer? Gynecol Oncol. 2013 Sep; 130(3):565-9. PMID: 23800698; PMCID: PMC4059202.
      Citations: 25     Fields:    Translation:HumansCells
    53. Song H, Kwan SY, Izaguirre DI, Zu Z, Tsang YT, Tung CS, King ER, Mok SC, Gershenson DM, Wong KK. PAX2 Expression in Ovarian Cancer. Int J Mol Sci. 2013 Mar 15; 14(3):6090-105. PMID: 23502471; PMCID: PMC3634442.
      Citations: 16     Fields:    
    54. Zaid TM, Yeung TL, Thompson MS, Leung CS, Harding T, Co NN, Schmandt RS, Kwan SY, Rodriguez-Aguay C, Lopez-Berestein G, Sood AK, Wong KK, Birrer MJ, Mok SC. Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer. Clin Cancer Res. 2013 Feb 15; 19(4):809-20. PMID: 23344261; PMCID: PMC3577959.
      Citations: 40     Fields:    Translation:HumansAnimalsCells
    55. Vathipadiekal V, Saxena D, Mok SC, Hauschka PV, Ozbun L, Birrer MJ. Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer. PLoS One. 2012; 7(1):e29079. PMID: 22272227; PMCID: PMC3260150.
      Citations: 58     Fields:    Translation:HumansAnimalsCells
    56. Stany MP, Vathipadiekal V, Ozbun L, Stone RL, Mok SC, Xue H, Kagami T, Wang Y, McAlpine JN, Bowtell D, Gout PW, Miller DM, Gilks CB, Huntsman DG, Ellard SL, Wang YZ, Vivas-Mejia P, Lopez-Berestein G, Sood AK, Birrer MJ. Identification of novel therapeutic targets in microdissected clear cell ovarian cancers. PLoS One. 2011; 6(7):e21121. PMID: 21754983; PMCID: PMC3130734.
      Citations: 43     Fields:    Translation:HumansAnimalsCells
    57. King ER, Zu Z, Tsang YT, Deavers MT, Malpica A, Mok SC, Gershenson DM, Wong KK. The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma. Gynecol Oncol. 2011 Oct; 123(1):13-8. PMID: 21726895; PMCID: PMC3171566.
      Citations: 23     Fields:    Translation:HumansCells
    58. Chung TK, Lau TS, Cheung TH, Yim SF, Lo KW, Siu NS, Chan LK, Yu MY, Kwong J, Doran G, Barroilhet LM, Ng AS, Wong RR, Wang VW, Mok SC, Smith DI, Berkowitz RS, Wong YF. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer. 2012 Mar 01; 130(5):1036-45. PMID: 21400511.
      Citations: 101     Fields:    Translation:HumansCells
    59. King ER, Tung CS, Tsang YT, Zu Z, Lok GT, Deavers MT, Malpica A, Wolf JK, Lu KH, Birrer MJ, Mok SC, Gershenson DM, Wong KK. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer. Am J Surg Pathol. 2011 Jun; 35(6):904-12. PMID: 21451362; PMCID: PMC3095702.
      Citations: 44     Fields:    Translation:HumansCells
    60. Schauer IG, Sood AK, Mok S, Liu J. Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer. Neoplasia. 2011 May; 13(5):393-405. PMID: 21532880; PMCID: PMC3084616.
      Citations: 87     Fields:    Translation:HumansCells
    61. Young JL, Koon EC, Kwong J, Welch WR, Muto MG, Berkowitz RS, Mok SC. Differential hRad17 expression by histologic subtype of ovarian cancer. J Ovarian Res. 2011 Mar 30; 4(1):6. PMID: 21450056; PMCID: PMC3077316.
      Citations: 1     Fields:    
    62. Yates MS, Meyer LA, Deavers MT, Daniels MS, Keeler ER, Mok SC, Gershenson DM, Lu KH. Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis. Cancer Prev Res (Phila). 2011 Mar; 4(3):463-70. PMID: 21278312; PMCID: PMC3048908.
      Citations: 21     Fields:    Translation:Humans
    63. Gao Z, Xu X, McClane B, Zeng Q, Litkouhi B, Welch WR, Berkowitz RS, Mok SC, Garner EI. C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin. Clin Cancer Res. 2011 Mar 01; 17(5):1065-74. PMID: 21123456; PMCID: PMC3075966.
      Citations: 24     Fields:    Translation:HumansAnimalsCells
    64. Wong KK, Tsang YT, Deavers MT, Mok SC, Zu Z, Sun C, Malpica A, Wolf JK, Lu KH, Gershenson DM. BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas. Am J Pathol. 2010 Oct; 177(4):1611-7. PMID: 20802181; PMCID: PMC2947258.
      Citations: 77     Fields:    Translation:Humans
    65. Ghosh S, Albitar L, LeBaron R, Welch WR, Samimi G, Birrer MJ, Berkowitz RS, Mok SC. Up-regulation of stromal versican expression in advanced stage serous ovarian cancer. Gynecol Oncol. 2010 Oct; 119(1):114-20. PMID: 20619446; PMCID: PMC3000175.
      Citations: 38     Fields:    Translation:HumansAnimalsCells
    66. Zhang L, Wang D, Jiang W, Edwards D, Qiu W, Barroilhet LM, Rho JH, Jin L, Seethappan V, Vitonis A, Wang J, Mok SC, Crum C, Cramer DW, Ye B. Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium. Reprod Biol Endocrinol. 2010 Jun 24; 8:74. PMID: 20576130; PMCID: PMC2903602.
      Citations: 12     Fields:    Translation:HumansCells
    67. Mok SC, Bonome T, Vathipadiekal V, Bell A, Johnson ME, Wong KK, Park DC, Hao K, Yip DK, Donninger H, Ozbun L, Samimi G, Brady J, Randonovich M, Pise-Masison CA, Barrett JC, Wong WH, Welch WR, Berkowitz RS, Birrer MJ. A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell. 2009 Dec 08; 16(6):521-32. PMID: 19962670; PMCID: PMC3008560.
      Citations: 129     Fields:    Translation:HumansCells
    68. Thompson MS, Mok SC. Immunopathogenesis of ovarian cancer. Minerva Med. 2009 Oct; 100(5):357-70. PMID: 19910889.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    69. Lu KH, Yates MS, Mok SC. The monkey, the hen, and the mouse: models to advance ovarian cancer chemoprevention. Cancer Prev Res (Phila). 2009 Sep; 2(9):773-5. PMID: 19737981.
      Citations: 9     Fields:    Translation:HumansAnimals
    70. Alper O, Stetler-Stevenson WG, Harris LN, Leitner WW, Ozdemirli M, Hartmann D, Raffeld M, Abu-Asab M, Byers S, Zhuang Z, Oldfield EH, Tong Y, Bergmann-Leitner E, Criss WE, Nagasaki K, Mok SC, Cramer DW, Karaveli FS, Goldbach-Mansky R, Leo P, Stromberg K, Weil RJ. Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma. Cancer Sci. 2009 Sep; 100(9):1748-56. PMID: 19594548; PMCID: PMC2788299.
      Citations: 23     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    71. Tung CS, Mok SC, Tsang YT, Zu Z, Song H, Liu J, Deavers MT, Malpica A, Wolf JK, Lu KH, Gershenson DM, Wong KK. PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas. Mod Pathol. 2009 Sep; 22(9):1243-50. PMID: 19525924; PMCID: PMC2736318.
      Citations: 32     Fields:    Translation:Humans
    72. Kwong J, Chan FL, Wong KK, Birrer MJ, Archibald KM, Balkwill FR, Berkowitz RS, Mok SC. Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells. Neoplasia. 2009 Jun; 11(6):529-41. PMID: 19484142; PMCID: PMC2685442.
      Citations: 20     Fields:    Translation:HumansCells
    73. Chung TK, Cheung TH, Huen NY, Wong KW, Lo KW, Yim SF, Siu NS, Wong YM, Tsang PT, Pang MW, Yu MY, To KF, Mok SC, Wang VW, Li C, Cheung AY, Doran G, Birrer MJ, Smith DI, Wong YF. Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women. Int J Cancer. 2009 Mar 15; 124(6):1358-65. PMID: 19065659; PMCID: PMC6953413.
      Citations: 82     Fields:    Translation:HumansCells
    74. Socha MJ, Said N, Dai Y, Kwong J, Ramalingam P, Trieu V, Desai N, Mok SC, Motamed K. Aberrant promoter methylation of SPARC in ovarian cancer. Neoplasia. 2009 Feb; 11(2):126-35. PMID: 19177197; PMCID: PMC2631137.
      Citations: 40     Fields:    Translation:HumansCells
    75. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, Deavers MT, Mourad-Zeidan A, Wang H, Mueller P, Lenburg ME, Gray JW, Mok S, Birrer MJ, Lopez-Berestein G, Coleman RL, Bar-Eli M, Sood AK. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med. 2008 Dec 18; 359(25):2641-50. PMID: 19092150; PMCID: PMC2710981.
      Citations: 348     Fields:    Translation:HumansCells
    76. Callahan MJ, Nagymanyoki Z, Bonome T, Johnson ME, Litkouhi B, Sullivan EH, Hirsch MS, Matulonis UA, Liu J, Birrer MJ, Berkowitz RS, Mok SC. Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer. Clin Cancer Res. 2008 Dec 01; 14(23):7667-73. PMID: 19047092; PMCID: PMC3000165.
      Citations: 58     Fields:    Translation:HumansCells
    77. Nevadunsky NS, Barbieri JS, Kwong J, Merritt MA, Welch WR, Berkowitz RS, Mok SC. RUNX3 protein is overexpressed in human epithelial ovarian cancer. Gynecol Oncol. 2009 Feb; 112(2):325-30. PMID: 18937968.
      Citations: 22     Fields:    Translation:HumansCells
    78. Park DC, Yeo SG, Wilson MR, Yerbury JJ, Kwong J, Welch WR, Choi YK, Birrer MJ, Mok SC, Wong KK. Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer. Neoplasia. 2008 Sep; 10(9):964-72. PMID: 18714397; PMCID: PMC2517641.
      Citations: 19     Fields:    Translation:HumansCells
    79. Cheung KK, Mok SC, Rezaie P, Chan WY. Dynamic expression of Dab2 in the mouse embryonic central nervous system. BMC Dev Biol. 2008 Aug 04; 8:76. PMID: 18680569; PMCID: PMC2527319.
      Citations: 9     Fields:    Translation:Animals
    80. Nagymanyoki Z, Callahan MJ, Parast MM, Fulop V, Mok SC, Berkowitz RS. Immune cell profiling in intraplacental and postmolar choriocarcinomas. J Reprod Med. 2008 Aug; 53(8):558-64. PMID: 18773618.
      Citations: 2     Fields:    Translation:HumansCells
    81. Nagymanyoki Z, Growdon WB, Sarno J, Callahan MJ, Parast MM, Fulop V, Mok SC, Horowitz N, Berkowitz RS. Vascularization and expression of angiogenic factors in partial and complete molar pregnancies. J Reprod Med. 2008 Aug; 53(8):589-94. PMID: 18773623.
      Citations: 1     Fields:    Translation:Humans
    82. Aponte M, Jiang W, Lakkis M, Li MJ, Edwards D, Albitar L, Vitonis A, Mok SC, Cramer DW, Ye B. Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer. Cancer Res. 2008 Jul 15; 68(14):5839-48. PMID: 18632638; PMCID: PMC2586603.
      Citations: 43     Fields:    Translation:HumansCells
    83. Nagymanyoki Z, Butler MO, Callahan MJ, Parast MM, Fulop V, Mok SC, Berkowitz RS. Antigen-specific T cell immune response detected by skewed T cell receptor usage in normal placenta and complete molar pregnancy. J Reprod Med. 2008 Jul; 53(7):528-34. PMID: 18720929.
      Citations:    Fields:    Translation:HumansCells
    84. Wang D, Zhao Z, Caperell-Grant A, Yang G, Mok SC, Liu J, Bigsby RM, Xu Y. S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells. Mol Cancer Ther. 2008 Jul; 7(7):1993-2002. PMID: 18645009; PMCID: PMC2649755.
      Citations: 31     Fields:    Translation:HumansCells
    85. Litkouhi B, Litkouhi B, Fleming E, Welch WR, Berkowitz RS, Birrer MJ, Mok SC. Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms. Gynecol Oncol. 2008 May; 109(2):234-9. PMID: 18331757.
      Citations: 9     Fields:    Translation:HumansCells
    86. Gagnon A, Kim JH, Schorge JO, Ye B, Liu B, Hasselblatt K, Welch WR, Bandera CA, Mok SC. Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients. Clin Cancer Res. 2008 Feb 01; 14(3):764-71. PMID: 18245537.
      Citations: 25     Fields:    Translation:HumansCells
    87. Stany MP, Bonome T, Wamunyokoli F, Zorn K, Ozbun L, Park DC, Hao K, Boyd J, Sood AK, Gershenson DM, Berkowitz RS, Mok SC, Birrer MJ. Classification of ovarian cancer: a genomic analysis. Adv Exp Med Biol. 2008; 622:23-33. PMID: 18546616; PMCID: PMC6953390.
      Citations: 5     Fields:    Translation:Humans
    88. Tung CS, Wong KK, Mok SC. Biomarker discovery in ovarian cancer. Womens Health (Lond). 2008 Jan; 4:27-40. PMID: 19072449.
      Citations: 7     Fields:    Translation:Humans
    89. Koon EC, Ma PC, Salgia R, Welch WR, Christensen JG, Berkowitz RS, Mok SC. Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion. Int J Gynecol Cancer. 2008 Sep-Oct; 18(5):976-84. PMID: 18021219.
      Citations: 17     Fields:    Translation:HumansCells
    90. Nagymanyoki Z, Callahan MJ, Parast MM, Berkowitz RS, Mok SC, Fulop V. Overexpression of laminin receptor 1 on decidual cells in partial and complete mole. Gynecol Oncol. 2008 Jan; 108(1):121-5. PMID: 17928039.
      Citations: 1     Fields:    Translation:Humans
    91. Nagymanyoki Z, Callahan MJ, Parast MM, Fulop V, Mok SC, Berkowitz RS. Immune cell profiling in normal pregnancy, partial and complete molar pregnancy. Gynecol Oncol. 2007 Nov; 107(2):292-7. PMID: 17878059.
      Citations: 4     Fields:    Translation:HumansCells
    92. Birrer MJ, Johnson ME, Hao K, Wong KK, Park DC, Bell A, Welch WR, Berkowitz RS, Mok SC. Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas. J Clin Oncol. 2007 Jun 01; 25(16):2281-7. PMID: 17538174.
      Citations: 60     Fields:    Translation:HumansCells
    93. Lee S, Garner EI, Welch WR, Berkowitz RS, Mok SC. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma. Gynecol Oncol. 2007 Aug; 106(2):311-7. PMID: 17532031; PMCID: PMC1995602.
      Citations: 24     Fields:    Translation:Humans
    94. Litkouhi B, Kwong J, Lo CM, Smedley JG, McClane BA, Aponte M, Gao Z, Sarno JL, Hinners J, Welch WR, Berkowitz RS, Mok SC, Garner EI. Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin. Neoplasia. 2007 Apr; 9(4):304-14. PMID: 17460774; PMCID: PMC1854850.
      Citations: 39     Fields:    Translation:HumansCells
    95. Ye B, Gagnon A, Mok SC. Recent technical strategies to identify diagnostic biomarkers for ovarian cancer. Expert Rev Proteomics. 2007 Feb; 4(1):121-31. PMID: 17288520.
      Citations: 5     Fields:    Translation:Humans
    96. Mok SC, Kwong J, Welch WR, Samimi G, Ozbun L, Bonome T, Birrer MJ, Berkowitz RS, Wong KK. Etiology and pathogenesis of epithelial ovarian cancer. Dis Markers. 2007; 23(5-6):367-76. PMID: 18057520; PMCID: PMC3851194.
      Citations: 18     Fields:    Translation:Humans
    97. Said NA, Najwer I, Socha MJ, Fulton DJ, Mok SC, Motamed K. SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk. Neoplasia. 2007 Jan; 9(1):23-35. PMID: 17325741; PMCID: PMC1803033.
      Citations: 26     Fields:    Translation:HumansCells
    98. Mok SC, Elias KM, Wong KK, Ho K, Bonome T, Birrer MJ. Biomarker discovery in epithelial ovarian cancer by genomic approaches. Adv Cancer Res. 2007; 96:1-22. PMID: 17161674.
      Citations: 6     Fields:    Translation:HumansAnimals
    99. Samimi G, Ozbun L, Johnson ME, Mok SC, Birrer MJ. Biomarkers of mucinous tumors of the ovary. Dis Markers. 2007; 23(5-6):389-96. PMID: 18057522; PMCID: PMC3851369.
      Citations: 1     Fields:    Translation:Humans
    100. Nishimura S, Tsuda H, Ito K, Jobo T, Yaegashi N, Inoue T, Sudo T, Berkowitz RS, Mok SC. Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organs. Hum Pathol. 2007 Jan; 38(1):134-9. PMID: 16996567.
      Citations: 8     Fields:    Translation:HumansCells
    101. Sunde JS, Donninger H, Wu K, Johnson ME, Pestell RG, Rose GS, Mok SC, Brady J, Bonome T, Birrer MJ. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer. Cancer Res. 2006 Sep 01; 66(17):8404-12. PMID: 16951150.
      Citations: 50     Fields:    Translation:HumansCells
    102. Kim KS, Sengupta S, Berk M, Kwak YG, Escobar PF, Belinson J, Mok SC, Xu Y. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo. Cancer Res. 2006 Aug 15; 66(16):7983-90. PMID: 16912173.
      Citations: 70     Fields:    Translation:HumansCells
    103. Park DC, Yeo SG, Shin EY, Mok SC, Kim DH. Clusterin confers paclitaxel resistance in cervical cancer. Gynecol Oncol. 2006 Dec; 103(3):996-1000. PMID: 16890274.
      Citations: 7     Fields:    Translation:HumansCells
    104. Huang KC, Park DC, Ng SK, Lee JY, Ni X, Ng WC, Bandera CA, Welch WR, Berkowitz RS, Mok SC, Ng SW. Selenium binding protein 1 in ovarian cancer. Int J Cancer. 2006 May 15; 118(10):2433-40. PMID: 16380993.
      Citations: 51     Fields:    Translation:HumansCells
    105. Kwong J, Lee JY, Wong KK, Zhou X, Wong DT, Lo KW, Welch WR, Berkowitz RS, Mok SC. Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer. Neoplasia. 2006 Apr; 8(4):268-78. PMID: 16756719; PMCID: PMC1600675.
      Citations: 34     Fields:    Translation:HumansCells
    106. Wamunyokoli FW, Bonome T, Lee JY, Feltmate CM, Welch WR, Radonovich M, Pise-Masison C, Brady J, Hao K, Berkowitz RS, Mok S, Birrer MJ. Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance. Clin Cancer Res. 2006 Feb 01; 12(3 Pt 1):690-700. PMID: 16467078.
      Citations: 28     Fields:    Translation:Humans
    107. Ye B, Skates S, Mok SC, Horick NK, Rosenberg HF, Vitonis A, Edwards D, Sluss P, Han WK, Berkowitz RS, Cramer DW. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clin Cancer Res. 2006 Jan 15; 12(2):432-41. PMID: 16428483.
      Citations: 46     Fields:    Translation:HumansCells
    108. Hashiguchi Y, Tsuda H, Bandera CA, Nishimura S, Inoue T, Kawamura N, Berkowitz RS, Mok SC. Comparison of osteopontin expression in endometrioid endometrial cancer and ovarian endometrioid cancer. Med Oncol. 2006; 23(2):205-12. PMID: 16720920.
      Citations: 5     Fields:    Translation:HumansCellsCTClinical Trials
    109. Feinberg BB, Jack RM, Mok SC, Anderson DJ. Low erythrocyte complement receptor type 1 (CR1, CD35) expression in preeclamptic gestations. Am J Reprod Immunol. 2005 Dec; 54(6):352-7. PMID: 16305660.
      Citations: 2     Fields:    Translation:HumansCells
    110. Bonome T, Lee JY, Park DC, Radonovich M, Pise-Masison C, Brady J, Gardner GJ, Hao K, Wong WH, Barrett JC, Lu KH, Sood AK, Gershenson DM, Mok SC, Birrer MJ. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer Res. 2005 Nov 15; 65(22):10602-12. PMID: 16288054.
      Citations: 113     Fields:    Translation:Humans
    111. Hashiguchi Y, Tsuda H, Inoue T, Berkowitz RS, Mok SC. PTEN expression in clear cell adenocarcinoma of the ovary. Gynecol Oncol. 2006 Apr; 101(1):71-5. PMID: 16290000.
      Citations: 27     Fields:    Translation:Humans
    112. Feltmate CM, Lee KR, Johnson M, Schorge JO, Wong KK, Hao K, Welch WR, Bell DA, Berkowitz RS, Mok SC. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas. Clin Cancer Res. 2005 Nov 01; 11(21):7651-7. PMID: 16278384.
      Citations: 6     Fields:    Translation:Humans
    113. Tsuda H, Ito YM, Ohashi Y, Wong KK, Hashiguchi Y, Welch WR, Berkowitz RS, Birrer MJ, Mok SC. Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 1):6880-8. PMID: 16203778.
      Citations: 21     Fields:    Translation:HumansCells
    114. Wang V, Li C, Lin M, Welch W, Bell D, Wong YF, Berkowitz R, Mok SC, Bandera CA. Ovarian cancer is a heterogeneous disease. Cancer Genet Cytogenet. 2005 Sep; 161(2):170-3. PMID: 16102589.
      Citations: 18     Fields:    Translation:Humans
    115. Rosen DG, Wang L, Atkinson JN, Yu Y, Lu KH, Diamandis EP, Hellstrom I, Mok SC, Liu J, Bast RC. Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol. 2005 Nov; 99(2):267-77. PMID: 16061277.
      Citations: 106     Fields:    Translation:HumansCells
    116. Qin S, Ferdinand AS, Richie JP, O'Leary MP, Mok SC, Liu BC. Chromatofocusing fractionation and two-dimensional difference gel electrophoresis for low abundance serum proteins. Proteomics. 2005 Aug; 5(12):3183-92. PMID: 16035113.
      Citations: 8     Fields:    Translation:Humans
    117. Zhou X, Rao NP, Cole SW, Mok SC, Chen Z, Wong DT. Progress in concurrent analysis of loss of heterozygosity and comparative genomic hybridization utilizing high density single nucleotide polymorphism arrays. Cancer Genet Cytogenet. 2005 May; 159(1):53-7. PMID: 15860358.
      Citations: 10     Fields:    Translation:HumansCells
    118. Drapkin R, von Horsten HH, Lin Y, Mok SC, Crum CP, Welch WR, Hecht JL. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res. 2005 Mar 15; 65(6):2162-9. PMID: 15781627.
      Citations: 181     Fields:    Translation:HumansCells
    119. Kwong J, Lo KW, Chow LS, To KF, Choy KW, Chan FL, Mok SC, Huang DP. Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma. Neoplasia. 2005 Jan; 7(1):67-74. PMID: 15720818; PMCID: PMC1490316.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    120. Feltmate CM, Mok SC. Whole-genome allelotyping using laser microdissected tissue. Methods Mol Biol. 2005; 293:69-77. PMID: 16028411.
      Citations: 1     Fields:    Translation:Humans
    121. Huddleston HG, Wong KK, Welch WR, Berkowitz RS, Mok SC. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker. Gynecol Oncol. 2005 Jan; 96(1):77-83. PMID: 15589584.
      Citations: 17     Fields:    Translation:HumansCells
    122. Tsuda H, Birrer MJ, Ito YM, Ohashi Y, Lin M, Lee C, Wong WH, Rao PH, Lau CC, Berkowitz RS, Wong KK, Mok SC. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform. Cancer Genet Cytogenet. 2004 Dec; 155(2):97-107. PMID: 15571795.
      Citations: 10     Fields:    Translation:HumansCells
    123. Zhou X, Mok SC, Chen Z, Li Y, Wong DT. Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping array. Hum Genet. 2004 Sep; 115(4):327-30. PMID: 15290239.
      Citations: 32     Fields:    Translation:HumansCells
    124. Ni X, Zhang W, Huang KC, Wang Y, Ng SK, Mok SC, Berkowitz RS, Ng SW. Characterisation of human kallikrein 6/protease M expression in ovarian cancer. Br J Cancer. 2004 Aug 16; 91(4):725-31. PMID: 15305183; PMCID: PMC2364785.
      Citations: 18     Fields:    Translation:HumansCells
    125. Wong YF, Cheung TH, Lo KW, Wang VW, Chan CS, Ng TB, Chung TK, Mok SC. Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix. Cancer Lett. 2004 Aug 10; 211(2):227-34. PMID: 15219946.
      Citations: 15     Fields:    Translation:Humans
    126. Fulop V, Mok SC, Berkowitz RS. Molecular biology of gestational trophoblastic neoplasia: a review. J Reprod Med. 2004 Jun; 49(6):415-22. PMID: 15283047.
      Citations: 3     Fields:    Translation:Humans
    127. Schorge JO, Drake RD, Lee H, Skates SJ, Rajanbabu R, Miller DS, Kim JH, Cramer DW, Berkowitz RS, Mok SC. Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer. Clin Cancer Res. 2004 May 15; 10(10):3474-8. PMID: 15161704.
      Citations: 30     Fields:    Translation:HumansCells
    128. Zhou X, Li C, Mok SC, Chen Z, Wong DT. Whole genome loss of heterozygosity profiling on oral squamous cell carcinoma by high-density single nucleotide polymorphic allele (SNP) array. Cancer Genet Cytogenet. 2004 May; 151(1):82-4. PMID: 15120915.
      Citations: 9     Fields:    Translation:Humans
    129. Zhou X, Jordan RC, Mok S, Birrer MJ, Wong DT. DNA copy number abnormality of oral squamous cell carcinoma detected with cDNA array-based comparative genomic hybridization. Cancer Genet Cytogenet. 2004 May; 151(1):90-2. PMID: 15120918.
      Citations: 1     Fields:    Translation:HumansCells
    130. Terry KL, Sluss PM, Skates SJ, Mok SC, Ye B, Vitonis AF, Cramer DW. Blood and urine markers for ovarian cancer: a comprehensive review. Dis Markers. 2004; 20(2):53-70. PMID: 15322314; PMCID: PMC3839278.
      Citations: 25     Fields:    Translation:Humans
    131. Tsuda H, Bandera CA, Birrer MJ, Hashiguchi Y, Berkowitz RS, Mok SC. Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary. Oncology. 2004; 67(3-4):291-9. PMID: 15557791.
      Citations: 5     Fields:    Translation:HumansCells
    132. Zheng Y, Xu Y, Ye B, Lei J, Weinstein MH, O'Leary MP, Richie JP, Mok SC, Liu BC. Prostate carcinoma tissue proteomics for biomarker discovery. Cancer. 2003 Dec 15; 98(12):2576-82. PMID: 14669276.
      Citations: 16     Fields:    Translation:Humans
    133. Zorn KK, Jazaeri AA, Awtrey CS, Gardner GJ, Mok SC, Boyd J, Birrer MJ. Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies. Clin Cancer Res. 2003 Oct 15; 9(13):4811-8. PMID: 14581352.
      Citations: 39     Fields:    Translation:HumansCells
    134. Kim JH, Herlyn D, Wong KK, Park DC, Schorge JO, Lu KH, Skates SJ, Cramer DW, Berkowitz RS, Mok SC. Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer. Clin Cancer Res. 2003 Oct 15; 9(13):4782-91. PMID: 14581349.
      Citations: 29     Fields:    Translation:HumansCells
    135. Ye B, Cramer DW, Skates SJ, Gygi SP, Pratomo V, Fu L, Horick NK, Licklider LJ, Schorge JO, Berkowitz RS, Mok SC. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin Cancer Res. 2003 Aug 01; 9(8):2904-11. PMID: 12912935.
      Citations: 67     Fields:    Translation:HumansCells
    136. Ho SM, Lau KM, Mok SC, Syed V. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells. Oncogene. 2003 Jul 03; 22(27):4243-56. PMID: 12833147.
      Citations: 8     Fields:    Translation:HumansCells
    137. Bandera CA, Tsui HW, Mok SC, Tsui FW. Expression of cytokines and receptors in normal, immortalized, and malignant ovarian epithelial cell lines. Anticancer Res. 2003 Jul-Aug; 23(4):3151-7. PMID: 12926048.
      Citations: 3     Fields:    Translation:HumansCells
    138. Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, Mok SC, D'Andrea AD. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med. 2003 May; 9(5):568-74. PMID: 12692539.
      Citations: 211     Fields:    Translation:HumansCells
    139. Batorfi J, Fulop V, Kim JH, Genest DR, Doszpod J, Mok SC, Berkowitz RS. Osteopontin is down-regulated in hydatidiform mole. Gynecol Oncol. 2003 Apr; 89(1):134-9. PMID: 12694667.
      Citations: 2     Fields:    Translation:HumansCells
    140. Batorfi J, Ye B, Mok SC, Cseh I, Berkowitz RS, Fulop V. Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells. Gynecol Oncol. 2003 Mar; 88(3):424-8. PMID: 12648597.
      Citations: 3     Fields:    Translation:Humans
    141. Bandera CA, Ye B, Mok SC. New technologies for the identification of markers for early detection of ovarian cancer. Curr Opin Obstet Gynecol. 2003 Feb; 15(1):51-5. PMID: 12544502.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    142. Rathi A, Virmani AK, Schorge JO, Elias KJ, Maruyama R, Minna JD, Mok SC, Girard L, Fishman DA, Gazdar AF. Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women. Clin Cancer Res. 2002 Nov; 8(11):3324-31. PMID: 12429618.
      Citations: 40     Fields:    Translation:HumansCells
    143. Rao PH, Reuter V, Mok SC, Bosl GJ, Koul S, Murty VV, Kucherlapati RS, Chaganti RS, Bourdon V, Naef F. Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes. Cancer Res. 2002 Nov 01; 62(21):6218-23. PMID: 12414650.
      Citations: 14     Fields:    Translation:HumansCells
    144. Ganesan S, Silver DP, Greenberg RA, Avni D, Drapkin R, Miron A, Mok SC, Randrianarison V, Brodie S, Salstrom J, Rasmussen TP, Klimke A, Marrese C, Marahrens Y, Deng CX, Feunteun J, Livingston DM. BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell. 2002 Nov 01; 111(3):393-405. PMID: 12419249.
      Citations: 97     Fields:    Translation:HumansAnimalsCells
    145. Huang Y, Mok SC, Zimmermann A, Friess H, Kleeff J, B?chler MW. Down-regulation of DOC-2 in colorectal cancer points to its role as a tumor suppressor in this malignancy. Dis Colon Rectum. 2002 Sep; 45(9):1242-8. PMID: 12352243.
      Citations: 17     Fields:    Translation:HumansCells
    146. Huang KC, Rao PH, Lau CC, Heard E, Ng SK, Brown C, Mok SC, Berkowitz RS, Ng SW. Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther. 2002 Aug; 1(10):769-76. PMID: 12492109.
      Citations: 58     Fields:    Translation:HumansCells
    147. O'Regan A, Fleming C. Osteopontin as a biomarker for ovarian cancer. JAMA. 2002 Jun 26; 287(24):3208-9; author reply 3209-10. PMID: 12076209.
      Citations: 3     Fields:    Translation:Humans
    148. Garner EI, Stokes EE, Berkowitz RS, Mok SC, Cramer DW. Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer. Cancer Res. 2002 Jun 01; 62(11):3058-62. PMID: 12036914.
      Citations: 10     Fields:    Translation:HumansCells
    149. Tsui HW, Hasselblatt K, Martin A, Mok SC, Tsui FW. Molecular mechanisms underlying SHP-1 gene expression. Eur J Biochem. 2002 Jun; 269(12):3057-64. PMID: 12071971.
      Citations: 21     Fields:    Translation:HumansCells
    150. Fulop V, Mok SC, Gati I, Berkowitz RS. Recent advances in molecular biology of gestational trophoblastic diseases. A review. J Reprod Med. 2002 May; 47(5):369-79. PMID: 12063875.
      Citations:    Fields:    Translation:Humans
    151. Syed V, Ulinski G, Mok SC, Ho SM. Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells. J Natl Cancer Inst. 2002 Apr 17; 94(8):617-29. PMID: 11959895.
      Citations: 36     Fields:    Translation:HumansCells
    152. Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, Mok SC. Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA. 2002 Apr 03; 287(13):1671-9. PMID: 11926891.
      Citations: 114     Fields:    Translation:HumansCells
    153. Rao PH, Harris CP, Yan Lu X, Li XN, Mok SC, Lau CC. Multicolor spectral karyotyping of serous ovarian adenocarcinoma. Genes Chromosomes Cancer. 2002 Feb; 33(2):123-32. PMID: 11793438.
      Citations: 5     Fields:    Translation:HumansCells
    154. Ahmed N, Pansino F, Clyde R, Murthi P, Quinn MA, Rice GE, Agrez MV, Mok S, Baker MS. Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Carcinogenesis. 2002 Feb; 23(2):237-44. PMID: 11872628.
      Citations: 63     Fields:    Translation:HumansCells
    155. Wang SC, Makino K, Xia W, Kim JS, Im SA, Peng H, Mok SC, Singletary SE, Hung MC. DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway. Oncogene. 2001 Oct 18; 20(47):6960-4. PMID: 11687976.
      Citations: 21     Fields:    Translation:HumansCells
    156. Mok SC, Chao J, Skates S, Wong K, Yiu GK, Muto MG, Berkowitz RS, Cramer DW. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst. 2001 Oct 03; 93(19):1458-64. PMID: 11584061.
      Citations: 69     Fields:    Translation:HumansCellsPHPublic Health
    157. Ortiz BH, Ailawadi M, Colitti C, Muto MG, Deavers M, Silva EG, Berkowitz RS, Mok SC, Gershenson DM. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res. 2001 Oct 01; 61(19):7264-7. PMID: 11585764.
      Citations: 16     Fields:    Translation:Humans
    158. Syed V, Ulinski G, Mok SC, Yiu GK, Ho SM. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res. 2001 Sep 15; 61(18):6768-76. PMID: 11559549.
      Citations: 66     Fields:    Translation:HumansCells
    159. Yiu GK, Chan WY, Ng SW, Chan PS, Cheung KK, Berkowitz RS, Mok SC. SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. Am J Pathol. 2001 Aug; 159(2):609-22. PMID: 11485919; PMCID: PMC1850537.
      Citations: 79     Fields:    Translation:HumansCells
    160. Garrett AP, Lee KR, Colitti CR, Muto MG, Berkowitz RS, Mok SC. k-ras mutation may be an early event in mucinous ovarian tumorigenesis. Int J Gynecol Pathol. 2001 Jul; 20(3):244-51. PMID: 11444200.
      Citations: 18     Fields:    Translation:Humans
    161. Huang Y, Friess H, Kleeff J, Esposito I, Zhu Z, Liu S, Mok SC, Zimmermann A, B?chler MW. Doc-2/hDab2 expression is up-regulated in primary pancreatic cancer but reduced in metastasis. Lab Invest. 2001 Jun; 81(6):863-73. PMID: 11406647.
      Citations: 9     Fields:    Translation:HumansCells
    162. Wang VW, Bell DA, Berkowitz RS, Mok SC. Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. Cancer Res. 2001 May 15; 61(10):4169-74. PMID: 11358841.
      Citations: 15     Fields:    Translation:HumansCells
    163. Schwartz BM, Hong G, Morrison BH, Wu W, Baudhuin LM, Xiao YJ, Mok SC, Xu Y. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells. Gynecol Oncol. 2001 May; 81(2):291-300. PMID: 11330965.
      Citations: 41     Fields:    Translation:HumansCells
    164. Wong KK, Cheng RS, Mok SC. Identification of differentially expressed genes from ovarian cancer cells by MICROMAX cDNA microarray system. Biotechniques. 2001 Mar; 30(3):670-5. PMID: 11252802.
      Citations: 18     Fields:    Translation:HumansCells
    165. Arnold JM, Mok SC, Purdie D, Chenevix-Trench G. Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas. Br J Cancer. 2001 Feb 02; 84(3):352-9. PMID: 11161400; PMCID: PMC2363740.
      Citations: 8     Fields:    Translation:HumansCells
    166. Okubo T, Mok SC, Chen S. Regulation of aromatase expression in human ovarian surface epithelial cells. J Clin Endocrinol Metab. 2000 Dec; 85(12):4889-99. PMID: 11134158.
      Citations: 5     Fields:    Translation:HumansCells
    167. Rauh-Adelmann C, Lau KM, Sabeti N, Long JP, Mok SC, Ho SM. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines. Mol Carcinog. 2000 Aug; 28(4):236-46. PMID: 10972993.
      Citations: 21     Fields:    Translation:HumansCells
    168. Huang LW, Garrett AP, Schorge JO, Muto MG, Bell DA, Welch WR, Berkowitz RS, Mok SC. Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum. Am J Clin Pathol. 2000 Jul; 114(1):93-9. PMID: 10884804.
      Citations: 4     Fields:    Translation:HumansCells
    169. Huang LW, Garrett AP, Bell DA, Welch WR, Berkowitz RS, Mok SC. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors. Gynecol Oncol. 2000 Jun; 77(3):369-76. PMID: 10831344.
      Citations: 13     Fields:    Translation:Humans
    170. Tuncer ZS, Vegh GL, Fulop V, Genest DR, Mok SC, Berkowitz RS. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor. Gynecol Oncol. 2000 Jun; 77(3):389-93. PMID: 10831347.
      Citations: 14     Fields:    Translation:Humans
    171. Ng SW, Yiu GK, Liu Y, Huang LW, Palnati M, Jun SH, Berkowitz RS, Mok SC. Analysis of p73 in human borderline and invasive ovarian tumor. Oncogene. 2000 Apr 06; 19(15):1885-90. PMID: 10773878.
      Citations: 12     Fields:    Translation:HumansCells
    172. Garrett AP, Ng SW, Muto MG, Welch WR, Bell DA, Berkowitz RS, Mok SC. ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum. Gynecol Oncol. 2000 Apr; 77(1):105-11. PMID: 10739698.
      Citations:    Fields:    Translation:Humans
    173. Schorge JO, Miller YB, Qi LJ, Muto MG, Welch WR, Berkowitz RS, Mok SC. Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum. Gynecol Oncol. 2000 Mar; 76(3):369-72. PMID: 10684712.
      Citations: 6     Fields:    Translation:Humans
    174. Schorge JO, Muto MG, Lee SJ, Huang LW, Welch WR, Bell DA, Keung EZ, Berkowitz RS, Mok SC. BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis. Cancer Res. 2000 Mar 01; 60(5):1361-4. PMID: 10728699.
      Citations: 19     Fields:    Translation:Humans
    175. Huang LW, Garrett AP, Muto MG, Colitti CV, Bell DA, Welch WR, Berkowitz RS, Mok SC. Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum. Hum Pathol. 2000 Mar; 31(3):367-73. PMID: 10746681.
      Citations: 4     Fields:    Translation:HumansCells
    176. Chan WY, Cheung KK, Schorge JO, Huang LW, Welch WR, Bell DA, Berkowitz RS, Mok SC. Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol. 2000 Feb; 156(2):409-17. PMID: 10666369; PMCID: PMC1850061.
      Citations: 44     Fields:    Translation:Humans
    177. Vegh GL, Fulop V, Liu Y, Ng SW, Tuncer ZS, Genest DR, Paldi-Haris P, Foldi J, Mok SC, Berkowitz RS. Differential gene expression pattern between normal human trophoblast and choriocarcinoma cell lines: downregulation of heat shock protein-27 in choriocarcinoma in vitro and in vivo. Gynecol Oncol. 1999 Dec; 75(3):391-6. PMID: 10600295.
      Citations: 5     Fields:    Translation:HumansCells
    178. Vegh GL, Selcuk Tuncer Z, Fulop V, Genest DR, Mok SC, Berkowitz RS. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta. Gynecol Oncol. 1999 Nov; 75(2):248-53. PMID: 10525381.
      Citations: 8     Fields:    Translation:Humans
    179. Imyanitov EN, Birrell GW, Filippovich I, Sorokina N, Arnold J, Mould MA, Wright K, Walsh M, Mok SC, Lavin MF, Chenevix-Trench G, Khanna KK. Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target. Oncogene. 1999 Aug 12; 18(32):4640-2. PMID: 10467409.
      Citations: 4     Fields:    Translation:HumansCells
    180. Lau KM, Mok SC, Ho SM. Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc Natl Acad Sci U S A. 1999 May 11; 96(10):5722-7. PMID: 10318951; PMCID: PMC21927.
      Citations: 87     Fields:    Translation:HumansCells
    181. Ng SW, Liu Y, Hasselblatt KT, Mok SC, Berkowitz RS. A new human topoisomerase III that interacts with SGS1 protein. Nucleic Acids Res. 1999 Feb 15; 27(4):993-1000. PMID: 9927731; PMCID: PMC148278.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    182. Schorge JO, Mok SC. Understanding the pathogenesis of primary peritoneal carcinoma: involvement of the BRCA1 and p53 genes. Hum Pathol. 1999 Feb; 30(2):115-6. PMID: 10029436.
      Citations:    Fields:    Translation:Humans
    183. Iyengar TD, Ng S, Lau CC, Welch WR, Bell DA, Berkowitz RS, Mok SC. Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumors. Oncogene. 1999 Jan 07; 18(1):257-62. PMID: 9926941.
      Citations: 6     Fields:    Translation:HumansCells
    184. Lu KH, Cramer DW, Muto MG, Li EY, Niloff J, Mok SC. A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer. Obstet Gynecol. 1999 Jan; 93(1):34-7. PMID: 9916952.
      Citations: 8     Fields:    Translation:Humans
    185. Bandera CA, Muto MG, Schorge JO, Berkowitz RS, Rubin SC, Mok SC. BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum. Obstet Gynecol. 1998 Oct; 92(4 Pt 1):596-600. PMID: 9764635.
      Citations: 10     Fields:    Translation:Humans
    186. Fulop V, Colitti CV, Genest D, Berkowitz RS, Yiu GK, Ng SW, Szepesi J, Mok SC. DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases. Oncogene. 1998 Jul 30; 17(4):419-24. PMID: 9696034.
      Citations: 28     Fields:    Translation:HumansCells
    187. Bandera CA, Muto MG, Welch WR, Berkowitz RS, Mok SC. Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum. Oncogene. 1998 Jul 02; 16(26):3455-9. PMID: 9692553.
      Citations: 4     Fields:    Translation:HumansCells
    188. Schorge JO, Muto MG, Welch WR, Bandera CA, Rubin SC, Bell DA, Berkowitz RS, Mok SC. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst. 1998 Jun 03; 90(11):841-5. PMID: 9625172.
      Citations: 15     Fields:    Translation:HumansCells
    189. Auersperg N, Edelson MI, Mok SC, Johnson SW, Hamilton TC. The biology of ovarian cancer. Semin Oncol. 1998 Jun; 25(3):281-304. PMID: 9633841.
      Citations: 44     Fields:    Translation:HumansCells
    190. Lu KH, Bell DA, Welch WR, Berkowitz RS, Mok SC. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors. Cancer Res. 1998 Jun 01; 58(11):2328-30. PMID: 9622067.
      Citations: 12     Fields:    Translation:HumansCells
    191. Mok SC, Chan WY, Wong KK, Cheung KK, Lau CC, Ng SW, Baldini A, Colitti CV, Rock CO, Berkowitz RS. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene. 1998 May 07; 16(18):2381-7. PMID: 9620555.
      Citations: 52     Fields:    Translation:HumansCells
    192. Quayle AJ, Porter EM, Nussbaum AA, Wang YM, Brabec C, Yip KP, Mok SC. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol. 1998 May; 152(5):1247-58. PMID: 9588893; PMCID: PMC1858596.
      Citations: 108     Fields:    Translation:Humans
    193. Fulop V, Mok SC, Genest DR, Szigetvari I, Cseh I, Berkowitz RS. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med. 1998 Feb; 43(2):101-10. PMID: 9513871.
      Citations: 12     Fields:    Translation:HumansCells
    194. Fulop V, Mok SC, Genest DR, Gati I, Doszpod J, Berkowitz RS. p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med. 1998 Feb; 43(2):119-27. PMID: 9513873.
      Citations: 12     Fields:    Translation:Humans
    195. Colitti CV, Rodabaugh KJ, Welch WR, Berkowitz RS, Mok SC. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas. Oncogene. 1998 Jan 29; 16(4):555-9. PMID: 9484846.
      Citations: 6     Fields:    Translation:HumansCells
    196. Edelson MI, Lau CC, Colitti CV, Welch WR, Bell DA, Berkowitz RS, Mok SC. A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumors. Oncogene. 1998 Jan 15; 16(2):197-202. PMID: 9464537.
      Citations: 9     Fields:    Translation:HumansCells
    197. Edelson MI, Scherer SW, Tsui LC, Welch WR, Bell DA, Berkowitz RS, Mok SC. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas. Oncogene. 1997 Jun 19; 14(24):2979-84. PMID: 9205105.
      Citations: 11     Fields:    Translation:HumansCells
    198. Lu KH, Weitzel JN, Kodali S, Welch WR, Berkowitz RS, Mok SC. A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas. Cancer Res. 1997 Feb 01; 57(3):387-90. PMID: 9012461.
      Citations: 4     Fields:    Translation:HumansCells
    199. Anisowicz A, Sotiropoulou G, Stenman G, Mok SC, Sager R. A novel protease homolog differentially expressed in breast and ovarian cancer. Mol Med. 1996 Sep; 2(5):624-36. PMID: 8898378; PMCID: PMC2230195.
      Citations: 40     Fields:    Translation:HumansAnimalsCells
    200. Tangir J, Loughridge NS, Berkowitz RS, Muto MG, Bell DA, Welch WR, Mok SC. Frequent microsatellite instability in epithelial borderline ovarian tumors. Cancer Res. 1996 Jun 01; 56(11):2501-5. PMID: 8653685.
      Citations: 11     Fields:    Translation:HumansCells
    201. Wertheim I, Tangir J, Muto MG, Welch WR, Berkowitz RS, Chen WY, Mok SC. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors. Oncogene. 1996 May 16; 12(10):2147-53. PMID: 8668340.
      Citations: 4     Fields:    Translation:HumansCells
    202. Mok SC, Chan WY, Wong KK, Muto MG, Berkowitz RS. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. Oncogene. 1996 May 02; 12(9):1895-901. PMID: 8649850.
      Citations: 42     Fields:    Translation:HumansAnimalsCells
    203. Muto MG, Cramer DW, Tangir J, Berkowitz R, Mok S. Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls. Cancer Res. 1996 Mar 15; 56(6):1250-2. PMID: 8640808.
      Citations: 6     Fields:    Translation:HumansCells
    204. Tangir J, Muto MG, Berkowitz RS, Welch WR, Bell DA, Mok SC. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Oncogene. 1996 Feb 15; 12(4):735-40. PMID: 8632895.
      Citations: 8     Fields:    Translation:HumansCells
    205. Rodabaugh KJ, Biggs RB, Qureshi JA, Barrett AJ, Welch WR, Bell DA, Berkowitz RS, Mok SC. Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors. Oncogene. 1995 Oct 05; 11(7):1249-54. PMID: 7478544.
      Citations: 3     Fields:    Translation:HumansCells
    206. Mok SC, Kwok TT, Berkowitz RS, Barrett AJ, Tsui FW. Overexpression of the protein tyrosine phosphatase, nonreceptor type 6 (PTPN6), in human epithelial ovarian cancer. Gynecol Oncol. 1995 Jun; 57(3):299-303. PMID: 7774833.
      Citations: 24     Fields:    Translation:HumansCells
    207. Tsao SW, Mok SC, Fey EG, Fletcher JA, Wan TS, Chew EC, Muto MG, Knapp RC, Berkowitz RS. Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res. 1995 Jun; 218(2):499-507. PMID: 7796885.
      Citations: 58     Fields:    Translation:HumansCells
    208. Rodabaugh KJ, Blanchard G, Welch WR, Bell DA, Berkowitz RS, Mok SC. Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors. Cancer Res. 1995 May 15; 55(10):2169-72. PMID: 7743519.
      Citations: 4     Fields:    Translation:HumansCells
    209. Muto MG, Welch WR, Mok SC, Bandera CA, Fishbaugh PM, Tsao SW, Lau CC, Goodman HM, Knapp RC, Berkowitz RS. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res. 1995 Feb 01; 55(3):490-2. PMID: 7834614.
      Citations: 17     Fields:    Translation:HumansCells
    210. Wertheim I, Muto MG, Welch WR, Bell DA, Berkowitz RS, Mok SC. p53 gene mutation in human borderline epithelial ovarian tumors. J Natl Cancer Inst. 1994 Oct 19; 86(20):1549-51. PMID: 7932812.
      Citations: 3     Fields:    Translation:Humans
    211. Lau CC, Mok SC, Kelley A, Cramer D. Detection of a RsaI polymorphism within the human galactokinase gene (GK2) by PCR-SSCP. Hum Mol Genet. 1994 Oct; 3(10):1916. PMID: 7849734.
      Citations:    Fields:    Translation:HumansCells
    212. Chan WY, Ng TB, Rong SH, Yeung HW, Mok SC. Antiproliferative and teratogenic activities of the bishemisuccinates of 7 alpha-hydroxycholesterol and 7 beta-hydroxycholesterol. Gen Pharmacol. 1994 Jul; 25(4):767-72. PMID: 7958740.
      Citations:    Fields:    Translation:AnimalsCells
    213. Steller MA, Mok SC, Yeh J, Fulop V, Anderson DJ, Berkowitz RS. Effects of cytokines on epidermal growth factor receptor expression by malignant trophoblast cells in vitro. J Reprod Med. 1994 Mar; 39(3):209-16. PMID: 8035376.
      Citations:    Fields:    Translation:HumansCells
    214. Mok SC, Wong KK, Chan RK, Lau CC, Tsao SW, Knapp RC, Berkowitz RS. Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol Oncol. 1994 Feb; 52(2):247-52. PMID: 8314147.
      Citations: 54     Fields:    Translation:HumansCells
    215. Tsui HW, Mok S, de Souza L, Martin A, Tsui FW. Transcriptional analyses of the gene region that encodes human histidyl-tRNA synthetase: identification of a novel bidirectional regulatory element. Gene. 1993 Sep 15; 131(2):201-8. PMID: 8406012.
      Citations:    Fields:    Translation:HumansAnimalsCells
    216. Mok SC, Lo KW, Tsao SW. Direct cycle sequencing of mutated alleles detected by PCR single-strand conformation polymorphism analysis. Biotechniques. 1993 May; 14(5):790-4. PMID: 8512704.
      Citations: 3     Fields:    Translation:HumansCells
    217. Mok SC, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, Berkowitz RS, Tsao SW. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res. 1993 Apr 01; 53(7):1489-92. PMID: 8384077.
      Citations: 48     Fields:    Translation:HumansCells
    218. Tsui FW, Tsui HW, Mok S, Mlinaric I, Copeland NG, Gilbert DJ, Jenkins NA, Siminovitch KA. Molecular characterization and mapping of murine genes encoding three members of the stefin family of cysteine proteinase inhibitors. Genomics. 1993 Mar; 15(3):507-14. PMID: 8468045.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    219. Chew EC, Yeung AS, Chew SB, Mok SC, Liew CC. Immunogold localization of a nuclear protein at different stages of the cell cycle in normal and tumor cells. In Vivo. 1991 Jul-Aug; 5(4):433-40. PMID: 1810435.
      Citations: 1     Fields:    Translation:AnimalsCells
    220. Expression of Dab2, a tumor suppressor, in the human fetal hippocampus and neocortex. Neuroembryology and Aging. 5:182-190.
    221. T-Limfociták aktivációjának vizsgálata t-sejt-receptor variábilis bétalánc profil elemzésével normál placentában és mola terhességben. Magyar Noorvosok Lapja. 72:19-26.
    222. Erratum. British Journal of Cancer. 92:983.
    223. Komplett mola és normál méhlepény fehérjeprofilja lézervezérelt mikrodisszekcióval izolált trofoblasztsejteken. Magyar Noorvosok Lapja. 66:149-154.
    224. Multiple diseases discriminated by quantitation of blood transcriptome. Internet Journal of Genomics and Proteomics. 6.
    225. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1 . Oncotarget. 6:31702-31720.
    226. A gesztációs trofoblaszt betegségek immunológiája I. Magyar Noorvosok Lapja. 71:215-223.
    227. Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer. Oncotarget. 6:44551-44562.
    228. Monitoring of ovarian cancer cell invasion in real time with frequency-dependent impedance measurement. American Journal of Physiology - Cell Physiology. 311:C1040-C1047.
    229. Classification of ovarian cancer. Advances in Experimental Medicine and Biology. 622:23-33.
    230. Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nature Communications. 7.
    231. A zselatinázok és a zselatináz inhibitorok szerepe a terhességi trofoblaszt betegségekben és a normál lepényben. Magyar Noorvosok Lapja. 65:155-159.
    232. Cellular and molecular processes in ovarian cancer metastasis. A review in the theme. American Journal of Physiology - Cell Physiology. 309:C444-C456.
    233. Molecular Basis of Gynecologic Diseases. 309-322.
    234. Angiogenezis vizsgalata mola terhessegben. Magyar Noorvosok Lapja. 72:99-104.
    235. Identification of differentially expressed RNA in human ovarian carcinoma cells by arbitrarily primed PCR fingerprinting of total RNAs. International Journal of Oncology. 3:13-17.
    236. Inhibition of Dab2 expression with antisense oligodeoxynucleotides in mouse embryos. Neuroembryology and Aging. 5:89-99.
    237. Az osteopontin csökkent kifejezodésének újabb bizonyítékai mola hydatidosában. Magyar Noorvosok Lapja. 66:351-355.
    238. Pancreatic cancer-derived exosomes. Translational Cancer Research. 5:S697-S700.
    239. Global rna expression analysis of primary and recurrent ovarian tumors. Nature Genetics. 27:60.
    240. Loss of LKB1 in high-grade endometrial carcinoma. Cancer. 120:3457-3468.
    241. Az osteopontin gyengébb kifejezódése mola terhességben. Magyar Noorvosok Lapja. 66:89-94.
    242. Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth. Cell Metabolism. 24:685-700.
    243. Molecular Basis of Gynecologic Diseases. 465-487.
    244. Letter from the new editor-in-chief. Cancers. 8:1.
    MOK's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (737)
    Explore
    _
    Co-Authors (39)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _